• Beclin1 Deficiency Mitigates Doxorubicin Liver Injury via Fe

  2026-07-30

  This study uncovers a novel protective mechanism whereby Beclin1 deficiency alleviates doxorubicin-induced liver injury by inhibiting both ferroptosis and autophagy. The findings advance understanding of ferroptotic cell death in hepatic toxicity and highlight the potential of targeting Beclin1 and ferroptosis pathways for therapeutic intervention.

• Machine Learning Accelerates LNP Design for mRNA Vaccines

  2026-07-30

  This study introduces a machine learning (ML) framework to predict and optimize lipid nanoparticle (LNP) formulations for mRNA vaccine delivery, focusing on the mechanistic and empirical performance of ionizable cationic lipids such as Dlin-MC3-DMA. The findings demonstrate that ML-enabled virtual screening can reliably inform LNP composition, reducing experimental workload while identifying superior siRNA and mRNA delivery vehicles.

• WZ4003: Unveiling NUAK1/2 Inhibition for Disease Modeling

  2026-07-29

  WZ4003 is a potent NUAK1/2 inhibitor with distinct effects on cell migration, proliferation, and tau phosphorylation. Explore its mechanistic insights, advanced uses in disease modeling, and nuanced applications beyond standard kinase inhibition assays.

• Spliceosome Acetylation, DNA Repair, and PARP Inhibitor Sens

  2026-07-29

  This study uncovers how acetylation-dependent regulation of the core spliceosome component SmD2 modulates DNA damage repair and alters hepatocellular carcinoma (HCC) cells’ sensitivity to PARP inhibitors. By showing that SmD2 acetylation status controls splicing of critical DNA repair genes, the research suggests new combinatorial therapeutic strategies for HCC.

• Omeprazole (A2845): H+,K+-ATPase Inhibition for Gastric Acid

  2026-07-28

  Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor designed for rigorous scientific research on gastric acid secretion and antiulcer mechanisms. It should only be used in preclinical model systems, not for clinical or diagnostic applications.

• Rifampin in Advanced Synthetic Biology: Precision Control &

  2026-07-28

  Explore how rifampin, a rifamycin antibiotic, enables unprecedented precision in synthetic biology and transcriptional regulation. This article uniquely details advanced protocol strategies, mechanistic insights, and evidence-based assay optimization for researchers.

• Chlorambucil: Optimized Workflows for DNA Crosslinking Assay

  2026-07-27

  Chlorambucil stands apart as a nitrogen mustard alkylating agent, empowering cancer researchers with robust, reproducible DNA crosslinking and selective apoptosis induction. This guide distills recent breakthroughs and expert troubleshooting tips into actionable protocols, enabling precise cytotoxicity assays and translational workflows using APExBIO’s high-purity Chlorambucil.

• Applied Workflows with Clodronate Liposomes for In Vivo Macr

  2026-07-27

  Clodronate Liposomes enable targeted, tissue-specific macrophage clearance in live animal models, revealing immune mechanisms that conventional approaches cannot. This article translates cutting-edge research on phagocytosis and immune aging into practical protocols, troubleshooting insights, and advanced applications for immunology labs.

• Quercetin as a PI3K Inhibitor: Advanced Cancer & Liver Workf

  2026-07-26

  Quercetin's dual role as a PI3K inhibitor and ferroptosis modulator enables advanced, reproducible workflows in cancer and liver injury models. This guide details optimized protocols, troubleshooting strategies, and the latest research insights, empowering scientists to maximize APExBIO's Quercetin for robust preclinical studies.

• Iron Stress Remodels Enterocyte Metabolism and Inflammatory

  2026-07-25

  Navazesh and Ji’s 2025 study demonstrates that iron deficiency and excess, induced via deferiprone and ferric ammonium citrate, distinctly reprogram metabolism and inflammatory signaling in enterocytes. Their metabolomics-guided approach uncovers how iron imbalance impairs proliferation, disrupts key metabolic pathways, and modulates cytokine expression, offering new insights for intestinal and iron-targeted research.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Biomolec

  2026-07-24

  Cy3 NHS ester (non-sulfonated) enables precise fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides, supporting sensitive detection in biomedical imaging workflows. It is optimal for protocols requiring high signal in the orange spectrum and organic co-solvent compatibility. It is not suitable for aqueous-only labeling or for long-term storage in solution.

• Mdivi-1: Selective DRP1 Inhibitor for Advanced Apoptosis Ass

  2026-07-24

  Mdivi-1, a selective DRP1 inhibitor from APExBIO, empowers mitochondrial dynamics research with reproducible control over apoptosis and neuroprotection. Its robust, cell-permeable action and protocol flexibility drive breakthroughs in disease modeling and mechanistic studies.

• Erastin: Precision Ferroptosis Inducer for Advanced Cancer R

  2026-07-23

  Erastin, a gold-standard ferroptosis inducer from APExBIO, empowers selective induction of iron-dependent cell death in RAS/BRAF-mutant tumor models. This guide distills optimized workflows, troubleshooting insights, and translational advances, putting robust oxidative stress assays and combination immunotherapy protocols within reach.

• Cy3 NHS ester (non-sulfonated): Technical Protocol & Best Pr

  2026-07-23

  Cy3 NHS ester (non-sulfonated) provides precise amine-reactive fluorescent labeling of proteins, peptides, and oligonucleotides, with bright orange emission suited for imaging and biochemical quantification. It is appropriate for workflows that tolerate organic co-solvents but should be avoided for highly labile proteins or strictly aqueous protocols.

• AMPK–SQSTM1 Feedback Loop: Dual Antioxidant Activation in Tu

  2026-07-22

  This study reveals a double-positive feedback loop between AMPK and SQSTM1/p62, leading to concurrent activation of AMPK and NFE2L2/NRF2 under metabolic stress. The findings clarify mechanisms of metabolic and antioxidant adaptation in tumor cells, with implications for targeting stress responses in cancer research.

16327 records 1/1089 page Next 12345 下5页 Last page